SMA Europe online tool helps patients find clinical trials
SMA Europe has launched an online tool designed to help patients, doctors, and others in the spinal muscular…
Articles by Patricia Inacio, PhD
Video game may boost physical activity in children with SMA
The “Tales from the Magic Keep” exergame — a video game that uses body movements to promote physical activity —…
Spinraza helps restore key amino acid imbalance in severe SMA
Spinraza (nusinersen) helps correct a key amino acid deficiency in people with a severe form of spinal muscular…
DMTs may reduce risk of children’s bone fractures in SMA: Study
Disease-modifying therapies (DMTs) may help lower the risk of children’s bone fractures among young patients with spinal muscular atrophy…
Spinraza treatment won’t lead to kidney dysfunction, per study
Treatment with Spinraza (nusinersen), which was the first disease-modifying therapy to be approved for spinal muscular atrophy (SMA)…
Wearable cybernetic therapy shown to boost walking ability in SBMA
Training with a wearable robotic hybrid assistive limb (HAL) device over two years was found to markedly improve the walking…
SMA screening is now available to all newborns in Canada
Newborn screening for spinal muscular atrophy (SMA) is now available to all babies born in Canada. The milestone announcement…
SMA prevalence at birth lower than thought, US study says
The prevalence of spinal muscular atrophy (SMA) at birth in the U.S. is lower than the historic global SMA…
Phase 3 apitegromab topline data in SMA types 2, 3 due by year’s end
Scholar Rock remains on track to report topline results later this year from its ongoing Phase 3 clinical trial…
Cdk5 enzyme may be promising therapeutic target for SMA
Inhibiting an abnormally hyperactive protein called cyclin-dependent kinase 5 (Cdk5) significantly lessens the dysfunction and death of motor neurons, the…